- BIBW-2992 Dual EGFR/HER2 Inhibitor Oncolytic
[作者:Campas, C; Castaner, R; Bolos, J,期刊:Drugs of the Future, 页码:649-654 , 文章类型: Article,,卷期:2008年33-8]
BIBW-2992 is a potent, irreversible, orally active inhibitor of the epidermal growth factor receptor EGFR and HER2 tyrosine kinases. In preclinical studies, BIBW-2992 showed selectivity over other receptor classes and...
|